ProAssurance differentiates itself through deep underwriting expertise in complex, high-risk professional liability markets where specialized knowledge is critical. Its focused niche positioning in healthcare professional liability and workers' compensation provides pricing power and customer stickiness, though it faces exposure to liability trend inflation and claims frequency volatility inherent in its segments.
Cyborg Score Rationale
ProAssurance demonstrates solid fundamentals with strong market positioning in specialized niches and experienced underwriting capabilities. However, the specialty insurance sector faces headwinds from rising claims costs and inflation, analyst sentiment is mixed, and the company's small-cap valuation reflects limited growth visibility.
Top Insights
Core expertise in medical professional liability provides defensible competitive moat; healthcare liability insurance generates majority of revenues with recurring customer relationships
Workers' compensation segment provides geographic and product diversification across East, South, and Midwest regions, reducing concentration risk
Institutional ownership stable at 92.6% as of Q3 2025, indicating confidence from sophisticated investors; top holders include BlackRock (13.3%), Vanguard (10.8%), and Magnetar Capital (5.8%)
Analyst consensus neutral to slightly negative with $21.00 price target suggesting 11-12% downside risk; specialty insurance sector faces ongoing profitability pressure from inflation
Named Competitors
Medical Professional Liability Insurance — Largest physician-owned medical malpractice insurer in US; acquiring ProAssurance
Specialty Professional Liability — Global specialty insurer with professional liability segment; larger scale and capital base
Healthcare and Workers' Compensation — Diversified conglomerate with substantial specialty insurance operations across all segments
Recent Developments
(May 2025) Stockholders approved proposed acquisition by The Doctors Company, the nation's largest physician-owned medical malpractice insurer
(February 2025) Filed 2024 Form 10-K with annual earnings results
(August 2024) Released Q2 2024 earnings; segment performance data reported across specialty P&C and workers' compensation divisions
Open the full interactive ProAssurance Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.